Literature DB >> 18289469

[Serum types of enterovirus and clinical characteristics of 237 children with hand, foot and mouth disease in Shenzhen].

Shou-Bin Zhang1, Hua Liao, Cheng-Hui Huang, Qing-Yu Tan, Wei-Ling Zhang, Yan Huang, Kan Chen, Su-Qing Qiu, Si-Zhong Xing, Yue-Hong Liao.   

Abstract

OBJECTIVE: To study the clinical and epidemiologic characteristics and the serum types of enterovirus of hand, foot and mouth disease (HFMD) in children.
METHODS: The RT-nPCR method was established with universal primers within 5' untranslated region of enterovirus and VP1 region of Coxsackievirus A16 (CAV16) and enterovirus 71 (EV 71). Enteroviruses were detected with RT-nPCR in 237 children with HFMD. Clinical and epidemiologic characteristics and serum types of enterovirus of the patients with HFMD were studied.
RESULTS: The patients'age ranged from 7 months to 11 years (mean 4.2 +/- 0.5 years). The majority (94.5%) were less than 6 years old. HFMD was mostly seen in spring and winter (67.9%). Oral mucosal pox or ulcer as well as hand and foot rashes were observed in all 237 patients. Fever occurred in 141 patients (59.5%). Of the 237 patients, 133 (56.1%) were RT-nPCR positive. Of the 133 cases, 38 were positive for EV71, 64 were positive for CAV16, and 31 were negative for both EV71 and CAV16. The patients infected by different types of enteroviruses had similar clinical characteristics. Gene colon and sequence analysis for 12 strains of enteroviruses PCR positive products presented as EV71 (n=5), CAV16 (n=5), ECHO13 (n=1), and CAV5 (n=1).
CONCLUSIONS: HFMD tends to occur in younger children less than 6 years old. The majority are affected in spring and winter. EV71 and CAV16 are common pathogens of HFMD. There is no relationship between clinical characteristics and serum types of enteroviruses in HFMD patients.

Entities:  

Mesh:

Year:  2008        PMID: 18289469

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  7 in total

Review 1.  Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition).

Authors:  Xing-Wang Li; Xin Ni; Su-Yun Qian; Quan Wang; Rong-Meng Jiang; Wen-Bo Xu; Yu-Cai Zhang; Guang-Jun Yu; Qiang Chen; Yun-Xiao Shang; Cheng-Song Zhao; Hui Yu; Ting Zhang; Gang Liu; Hui-Ling Deng; Jie Gao; Xian-Gui Ran; Qiao-Zhi Yang; Bian-Li Xu; Xue-Yong Huang; Xing-Dong Wu; Yi-Xiao Bao; Yi-Ping Chen; Zhi-Hai Chen; Qing-Quan Liu; Guo-Ping Lu; Chun-Feng Liu; Rong-Bing Wang; Guo-Liang Zhang; Fang Gu; Hong-Mei Xu; Ying Li; Tao Yang
Journal:  World J Pediatr       Date:  2018-10-03       Impact factor: 2.764

Review 2.  The characteristics of blood glucose and WBC counts in peripheral blood of cases of hand foot and mouth disease in China: a systematic review.

Authors:  Yuyun Li; Runan Zhu; Yuan Qian; Jie Deng
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

3.  Public health services in Shenzhen: a case study.

Authors:  D Zhang; J Mou; J Q Cheng; S M Griffiths
Journal:  Public Health       Date:  2011-01       Impact factor: 2.427

4.  Crystal structure of human enterovirus 71 3C protease.

Authors:  Sheng Cui; Jing Wang; Tingting Fan; Bo Qin; Li Guo; Xiaobo Lei; Jianwei Wang; Meitian Wang; Qi Jin
Journal:  J Mol Biol       Date:  2011-03-17       Impact factor: 5.469

5.  Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation.

Authors:  Kuo-Feng Weng; Mei-Ling Li; Chuan-Tien Hung; Shin-Ru Shih
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

6.  Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation.

Authors:  Jing-Yi Lin; Mei-Ling Li; Shin-Ru Shih
Journal:  Nucleic Acids Res       Date:  2008-11-14       Impact factor: 16.971

7.  Inhibition of Enterovirus 71 replication by 7-hydroxyflavone and diisopropyl-flavon7-yl Phosphate.

Authors:  Jianmin Wang; Haoxiang Su; Ting Zhang; Jiang Du; Sheng Cui; Fan Yang; Qi Jin
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.